• The University of Western Australia (M505), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Prof Cheah is a Consultant Haematologist at Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine WA, Linear Clinical Research and Hollywood Private Hospital. He received his MBBS from the University of Western Australia in 2003 and completed post-graduate training in Clinical and Laboratory Haematology in Perth (Fremantle Hospital) and Melbourne. He completed Fellowships at Peter MacCallum Cancer Centre (Melbourne, Australia) and MD Anderson Cancer Center (Houston, Texas, USA).

Prof Cheah is the lymphoma lead and Fellowship Program Director Sir Charles Gairdner Hospital and Founder of Blood Cancer Research WA. His research interests are novel drug therapies and prevention of CNS relapse in lymphomas. He has authored >100 peer-reviewed publications, attracted >10 million dollars in competitive grant funding and reviews for major journals in the field. He was awarded Cancer Council WA Early Career Cancer Researcher of the Year in 2018 and WA 40 under 40 award 2019. 

He is passionate about improving access for Australian patients to the novel lymphoma treatments and training the next generation of lymphoma researchers. He delights in his young family and enjoys running and cycling in his spare time.

Roles and responsibilities

Prof Cheah is a Clinical Haematologist with subspecialty expertise is in the management of lymphoma. He teaches Haematology at an undergraduate and post-graduate level through UWA and Sir Charles Gairdner Hospital.

He is an active clinical investigator and serves as PI on multiple industry sponsored and investigator initiated trials evaluating new lymphoma drugs.

He provides inpatient and outpatient care to patients through the Haematology Department at Sir Charles Gairdner Hospital and Hollywood Private Hospitals; as a pathologist he provides laboratory diagnostic services through Pathwest Laboratory Medicine WA and Western Diagnostic Pathology. 

Future research

Developing an early phase clinical trials program exploring novel agents in patients with lymphoma.

Funding overview

AI, NHMRC project grant, 2013. "Phase I study of oral NMP in relapsed/refractory multiple myeloma." PI: Professor David Ritchie, Royal Melbourne Hospital.


NHMRC project grant 2018 APP 1142980

Title: Integrating immunity and genetics in Follicular Lymphoma to establish a prognostic score fit for the modern era

CIA: Maher Gandhi, CIG Chan Cheah

Value: $1,377,173

Medical Research Future Fund 2017 LCTRC APP 1152436

Title:An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies

CIA: Maher Gandhi, CIB Chan Cheah

Value: $1,586,476


Cancer Council WA collaborative cancer grant scheme 2017

Title: Designing better cellular and targeted therapies for lymphoma and leukaemia.

CIA: Bree Foley, CIC:Chan Cheah

Value: $50,000

Previous positions

Translational Research Fellow, Peter MacCallum Cancer Centre (Melbourne, Australia)
Lymphoma Fellow, MD Anderson Cancer Center (Houston, Texas, USA).

Industrial relevance

Principal investigator on numerous industry sponsored and academic cooperative group clinical trials.

Teaching overview

Lectures in Haematology in various units at UWA. Medical student supervisor through inpatient and outpatient clinics at Sir Charles Gairdner Hospital. 

Director of Fellowship Program at Sir Charles Gairdner Hospital / Blood Cancer Research WA.


Prof Cheah performs clinical research focused on improving outcomes for patients with lymphoma.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Medicine, Doctor of Medical Science, Improving the outcomes of patients with lymphoproliferative disorders , University of Melbourne

Award Date: 14 Apr 2014

Medicine, MBBS, The University of Western Australia

Award Date: 23 Apr 2003

Industry keywords

  • Drug Discovery
  • Medicine and Pharma
  • Biotechnology

Research expertise keywords

  • lymphoma


Dive into the research topics where Chan Cheah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or